CCCC
Price
$1.39
Change
-$0.11 (-7.33%)
Updated
May 14, 01:46 PM (EDT)
Capitalization
106.51M
84 days until earnings call
NTLA
Price
$8.32
Change
-$0.23 (-2.69%)
Updated
May 13 closing price
Capitalization
861.81M
78 days until earnings call
Ad is loading...

CCCC vs NTLA

Header iconCCCC vs NTLA Comparison
Open Charts CCCC vs NTLABanner chart's image
C4 Therapeutics
Price$1.39
Change-$0.11 (-7.33%)
Volume$1.1K
Capitalization106.51M
Intellia Therapeutics
Price$8.32
Change-$0.23 (-2.69%)
Volume$3.43M
Capitalization861.81M
CCCC vs NTLA Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. NTLA commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (CCCC: $1.50 vs. NTLA: $8.32)
Brand notoriety: CCCC and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 87% vs. NTLA: 99%
Market capitalization -- CCCC: $106.51M vs. NTLA: $861.81M
CCCC [@Biotechnology] is valued at $106.51M. NTLA’s [@Biotechnology] market capitalization is $861.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CCCC and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 8 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 3 bearish.
  • NTLA’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +6.38% price change this week, while NTLA (@Biotechnology) price change was +14.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.76%. For the same industry, the average monthly price growth was +7.67%, and the average quarterly price growth was -5.25%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($862M) has a higher market cap than CCCC($107M). NTLA YTD gains are higher at: -28.645 vs. CCCC (-58.333). CCCC has higher annual earnings (EBITDA): -103.37M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. CCCC (245M). CCCC has less debt than NTLA: CCCC (65.8M) vs NTLA (210M). NTLA has higher revenues than CCCC: NTLA (57.9M) vs CCCC (35.6M).
CCCCNTLACCCC / NTLA
Capitalization107M862M12%
EBITDA-103.37M-523.98M20%
Gain YTD-58.333-28.645204%
P/E RatioN/AN/A-
Revenue35.6M57.9M61%
Total Cash245M602M41%
Total Debt65.8M210M31%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCNTLA
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-5.06%
KYMR - CCCC
64%
Loosely correlated
-3.20%
CRBU - CCCC
56%
Loosely correlated
-4.31%
BEAM - CCCC
54%
Loosely correlated
-1.04%
PRME - CCCC
52%
Loosely correlated
-5.22%
NTLA - CCCC
52%
Loosely correlated
-2.69%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-2.69%
CRSP - NTLA
68%
Closely correlated
-0.98%
BEAM - NTLA
65%
Loosely correlated
-1.04%
RXRX - NTLA
60%
Loosely correlated
-2.80%
RCKT - NTLA
59%
Loosely correlated
-5.50%
ALLO - NTLA
58%
Loosely correlated
-3.42%
More